Study of Vaccine Efficacy in Health Care Workers (PSVEHCW)

04/03/2021
25/04/2024
EU PAS number:
EUPAS39736
Study
Planned
Study type

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medical condition to be studied

SARS-CoV-2 test positive
COVID-19 immunisation
Population studied

Age groups

  • Children (2 to < 12 years)
  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Special population of interest

Renal impaired
Hepatic impaired
Immunocompromised
Pregnant women

Estimated number of subjects

300000
Study design details

Main study objective

1. To determine the real-world efficacy of COVID-19 vaccination in HCWs. 2. To determine the effect of vaccinating HCWs on the risk of COVID-19 in individuals with whom they share a household as such an effect would be consistent with an effect of vaccination on transmission

Outcomes

Any case of COVID-19 defined as the first positive test for SARS-CoV-2. Hospitalisation with COVID-19 Severe COVID-19, ie COVID-19 resulting in ICU admission or death

Data analysis plan

Extended cox-models to estimate the hazard ratio for vaccination, treating vaccination as a time-varying covariate.